Inpatient Continuous Glucose Monitoring and Glycemic Outcomes

Overview

Journal J Diabetes Sci Technol

Specialty Endocrinology

Date 2017 Mar 15

PMID 28290224

Citations 18

Authors

David L Levitt

Kristi D Silver

Elias K Spanakis

Affiliations

Soon will be listed here.

Abstract

Continuous glucose monitoring (CGM) is commonly used in the outpatient setting to improve diabetes management. CGM can provide real-time glucose trends, detecting hyperglycemia and hypoglycemia before the onset of clinical symptoms. In 2011, at the time the Endocrine Society CGM guidelines were published, the society did not recommend inpatient CGM as its efficacy and safety were unknown. While many studies have subsequently evaluated inpatient CGM accuracy and reliability, glycemic outcome studies have not been widely published. In the non-ICU setting, investigational CGM studies have commonly blinded providers and patients to glucose data. Retrospective review of the glucose data reflects increased hypoglycemia detection with CGM. In the ICU setting, data are inconsistent whether CGM can improve glycemic outcomes. Studies have not focused on hospitalized patients with type 1 diabetes mellitus, the population most likely to benefit from inpatient CGM. This article reviews inpatient CGM glycemic outcomes in the non-ICU and ICU setting.

Citing Articles

Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients.

Cho S, Vigers T, Pyle L, Franklin A, Sopfe J, Jeney F Diabetes Technol Ther. 2022; 25(2):116-121.

PMID: 36511871 PMC: 9894599. DOI: 10.1089/dia.2022.0246.

Reliability of Inpatient CGM: Comparison to Standard of Care.

Price C, Ditton G, Russell G, Aloi J J Diabetes Sci Technol. 2021; 17(2):329-335.

PMID: 34911384 PMC: 10012376. DOI: 10.1177/19322968211062168.

Continuous glucose monitoring in the hospital: an update in the era of COVID-19.

Gothong C, Singh L, Satyarengga M, Spanakis E Curr Opin Endocrinol Diabetes Obes. 2021; 29(1):1-9.

PMID: 34845159 PMC: 8711300. DOI: 10.1097/MED.0000000000000693.

Consumer Wearables for Patient Monitoring in Otolaryngology: A State of the Art Review.

Somani S, Yu K, Chiu A, Sykes K, Villwock J Otolaryngol Head Neck Surg. 2021; 167(4):620-631.

PMID: 34813407 PMC: 10228711. DOI: 10.1177/01945998211061681.

Use of Continuous Glucose Monitoring in Non-ICU Hospital Settings for People With Diabetes: A Scoping Review of Emerging Benefits and Issues.

Clubbs Coldron B, Coates V, Khamis A, MacRury S J Diabetes Sci Technol. 2021; 17(2):467-473.

PMID: 34696622 PMC: 10012381. DOI: 10.1177/19322968211053652.

References

Ballesteros D, Martinez O, Blancas Gomez-Casero R, Martin Parra C, Lopez Matamala B, Estebanez B . Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock. Med Intensiva. 2014; 39(7):405-11. DOI: 10.1016/j.medin.2014.09.004. View

Joseph J, Torjman M, Strasma P . Vascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic Variability. J Diabetes Sci Technol. 2015; 9(4):725-38. PMC: 4525658. DOI: 10.1177/1932296815587938. View

Goldberg P, Siegel M, Sherwin R, Halickman J, Lee M, Bailey V . Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004; 27(2):461-7. DOI: 10.2337/diacare.27.2.461. View

Scuffi C, Lucarelli F, Valgimigli F . Minimizing the impact of time lag variability on accuracy evaluation of continuous glucose monitoring systems. J Diabetes Sci Technol. 2013; 6(6):1383-91. PMC: 3570879. DOI: 10.1177/193229681200600618. View

Wollersheim T, Engelhardt L, Pachulla J, Moergeli R, Koch S, Spies C . Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial. Ann Intensive Care. 2016; 6(1):70. PMC: 4954792. DOI: 10.1186/s13613-016-0167-z. View

Preiser J, Chase J, Hovorka R, Joseph J, Krinsley J, De Block C . Glucose Control in the ICU: A Continuing Story. J Diabetes Sci Technol. 2016; 10(6):1372-1381. PMC: 5094326. DOI: 10.1177/1932296816648713. View

. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008; 31(3):596-615. DOI: 10.2337/dc08-9017. View

Dungan K . Continuous Glucose Monitoring Use in Hospitalized Patients. Diabetes Technol Ther. 2015; 17(9):600-2. DOI: 10.1089/dia.2015.0156. View

Holzinger U, Warszawska J, Kitzberger R, Wewalka M, Miehsler W, Herkner H . Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2009; 33(3):467-72. PMC: 2827490. DOI: 10.2337/dc09-1352. View

10.

Schaupp L, Plank J, Kohler G, Schaller R, Wrighton C, Ellmerer M . Prediction of glucose concentration in post-cardiothoracic surgery patients using continuous glucose monitoring. Diabetes Technol Ther. 2011; 13(2):127-34. DOI: 10.1089/dia.2010.0117. View

11.

Umpierrez G, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P . Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011; 34(2):256-61. PMC: 3024330. DOI: 10.2337/dc10-1407. View

12.

Beck R, Calhoun P, Kollman C . Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther. 2012; 14(10):877-82. PMC: 3459006. DOI: 10.1089/dia.2012.0079. View

13.

Schaupp L, Donsa K, Neubauer K, Mader J, Aberer F, Holl B . Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy. Diabetes Technol Ther. 2015; 17(9):611-8. DOI: 10.1089/dia.2014.0343. View

14.

Kosiborod M, Gottlieb R, Sekella J, Peterman D, Grodzinsky A, Kennedy P . Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care. 2014; 2(1):e000037. PMC: 4212554. DOI: 10.1136/bmjdrc-2014-000037. View

15.

Siegelaar S, Barwari T, Hermanides J, Stooker W, van der Voort P, DeVries J . Accuracy and reliability of continuous glucose monitoring in the intensive care unit: a head-to-head comparison of two subcutaneous glucose sensors in cardiac surgery patients. Diabetes Care. 2011; 34(3):e31. PMC: 3041230. DOI: 10.2337/dc10-1882. View

16.

De Block C, Gios J, Verheyen N, Manuel-y-Keenoy B, Rogiers P, Jorens P . Randomized Evaluation of Glycemic Control in the Medical Intensive Care Unit Using Real-Time Continuous Glucose Monitoring (REGIMEN Trial). Diabetes Technol Ther. 2015; 17(12):889-98. DOI: 10.1089/dia.2015.0151. View

17.

Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F, Shubrook J . Continuous glucose monitoring system in a rural intensive care unit: a pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol. 2010; 4(3):636-44. PMC: 2901041. DOI: 10.1177/193229681000400318. View

18.

. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013; 36(4):1033-46. PMC: 3609540. DOI: 10.2337/dc12-2625. View

19.

Furnary A, Wu Y . Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract. 2006; 12 Suppl 3:22-6. DOI: 10.4158/EP.12.S3.22. View

20.

Logtenberg S, Kleefstra N, Snellen F, Groenier K, Slingerland R, Nierich A . Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther. 2009; 11(1):31-7. DOI: 10.1089/dia.2008.0028. View